We could not find any results for:
Make sure your spelling is correct or try broadening your search.
In the United States, a new drug application, or NDA, is the vehicle through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing. And news that...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MDP Canada NewsWire TORONTO, le 6 juin 2024 TORONTO, le 6 juin 2024 /CNW/ - L'OCRI...
Canadian Investment Regulatory Organization Trading Halt - MDP Canada NewsWire TORONTO, June 6, 2024 TORONTO, June 6, 2024 /CNW/ - The following issues have been halted by CIRO: Company: Medexus...
L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MDP Canada NewsWire TORONTO, le 6 juin 2024 TORONTO, le 6 juin 2024 /CNW/ - Reprise...
Canadian Investment Regulatory Organization Trade Resumption - MDP Canada NewsWire TORONTO, June 6, 2024 TORONTO, June 6, 2024 /CNW/ - Trading resumes in: Company: Medexus Pharmaceuticals...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MDP.DB Canada NewsWire TORONTO, le 16 oct. 2023 TORONTO, le 16 oct. 2023 /CNW/...
Canadian Investment Regulatory Organization Trading Halt - MDP.DB Canada NewsWire TORONTO, Oct. 16, 2023 TORONTO, Oct. 16, 2023 /CNW/ - The following issues have been halted by CIRO: Company:...
TORONTO and CHICAGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF), is pleased to announce that it has entered into an...
TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2023 Bloom...
TORONTO and CHICAGO, April 11, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce preliminary revenue estimates for the company’s fourth fiscal...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.44 | 21.8905472637 | 2.01 | 2.45 | 2.01 | 49261 | 2.14234516 | CS |
4 | -0.14 | -5.40540540541 | 2.59 | 2.6 | 1.72 | 40056 | 2.14164166 | CS |
12 | 0.03 | 1.23966942149 | 2.42 | 2.75 | 1.72 | 28111 | 2.35035051 | CS |
26 | 0.83 | 51.2345679012 | 1.62 | 2.75 | 1.5 | 33775 | 2.13955855 | CS |
52 | 0.88 | 56.050955414 | 1.57 | 3.16 | 1.44 | 45152 | 1.98463371 | CS |
156 | -0.63 | -20.4545454545 | 3.08 | 3.53 | 0.88 | 36940 | 2.05718395 | CS |
260 | -4.93 | -66.8021680217 | 7.38 | 7.9 | 0.88 | 38703 | 2.39589377 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions